Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis

Synlogic (Nasdaq:SYBX),
a clinical-stage company applying synthetic biology to probiotic
bacteria to develop novel …

Synlogic (Nasdaq:SYBX), a clinical-stage company applying synthetic biology to probiotic bacteria to develop novel ...